Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Ingo, Klein"'
Autor:
Matthias Kelm, Julia Schollbach, Friedrich Anger, Armin Wiegering, Ingo Klein, Christoph-Thomas Germer, Nicolas Schlegel, Volker Kunzmann, Stefan Löb
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background A prognostic benefit of additive chemotherapy in patients following resection of metachronous colorectal liver metastases (CRLM) remains controversial. Therefore, the goal of this retrospective study was to investigate the impact
Externí odkaz:
https://doaj.org/article/629a3adf4f594da1a4070f3cce3e69ec
Some Technical Remarks on Negations of Discrete Probability Distributions and Their Information Loss
Autor:
Ingo Klein
Publikováno v:
Mathematics, Vol 10, Iss 20, p 3893 (2022)
Negation of a discrete probability distribution was introduced by Yager. To date, several papers have been published discussing generalizations, properties, and applications of negation. The recent work by Wu et al. gives an excellent overview of the
Externí odkaz:
https://doaj.org/article/11924be0e5574a568667bf64ec7565e4
Autor:
Florian P, Reiter, Monika, Rau, Volker, Kunzmann, Ralph, Kickuth, Ingo, Klein, Olaf, Neumann, Albrecht, Stenzinger, Peter, Schirmacher, Andreas, Geier
Publikováno v:
Zeitschrift für Gastroenterologie. 61:71-75
Immunotherapy has become the standard of care in advanced HCC but is only approved in first- or second-line treatment. We report a patient with HCC refractory to several lines of tyrosine kinase inhibitors, who was treated with Ipilimumab and Nivolum
Autor:
Friedrich, Anger, Johan Friso, Lock, Ingo, Klein, Ingo, Hartlapp, Armin, Wiegering, Christoph-Thomas, Germer, Volker, Kunzmann, Stefan, Löb
Publikováno v:
Annals of Surgical Oncology. 29:8523-8533
Background Pancreatic adenocarcinoma (PDAC) patients with preoperative carbohydrate antigen 19-9 (CA19-9) serum levels higher than 500 U/ml are classified as biologically borderline resectable (BR-B). To date, the impact of cholestasis on preoperativ
Autor:
Johanna Wagner, Barbara Eiken, Imme Haubitz, Sven Lichthardt, Niels Matthes, Stefan Löb, Ingo Klein, Christoph-Thomas Germer, Armin Wiegering
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0209825 (2019)
BackgroundEpidural catheters are state of the art for postoperative analgesic in abdominal surgery. Due to neurolysis it can lead to postoperative urinary tract retention (POUR), which leads to prolonged bladder catheterization, which has an increase
Externí odkaz:
https://doaj.org/article/a024367864424cb5a976bff1fdb4d88d
Autor:
Elnaz Payani, Nikolaus Börner, Dionysios Kolliogiannis, Stefan Brunner, Ingo Klein, Ursula Ehmer, Gerald Denk, Christian M. Lange, Klaudja Ograja, Peter Dietrich, Jens Werner, Markus Guba
Publikováno v:
Langenbeck's Archives of Surgery. 408
Purpose The objective of this work was to uncover inequalities in access to liver transplantation in Bavaria, Germany. Methods For this purpose, the annual transplantation rate per 1 million inhabitants for the respective districts was determined fro
Autor:
Monika Doll, Ingo Klein
Publikováno v:
Communications in Statistics - Theory and Methods. :1-19
Autor:
Ingo Klein, Monika Doll
Publikováno v:
Entropy, Vol 22, Iss 1, p 91 (2020)
A distribution that maximizes an entropy can be found by applying two different principles. On the one hand, Jaynes (1957a,b) formulated the maximum entropy principle (MaxEnt) as the search for a distribution maximizing a given entropy under some giv
Externí odkaz:
https://doaj.org/article/62fd933be2ca419995ff51d593722a54
Autor:
Johannes Baur, Christoph Otto, Ulrich Steger, Stefan Klein-Hessling, Khalid Muhammad, Tobias Pusch, Krisna Murti, Rhoda Wismer, Christoph-Thomas Germer, Ingo Klein, Nora Müller, Edgar Serfling, Andris Avots
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transplantation medicine to suppress graft rejection. Both CsA and FK506 inhibit the phosphatase calcineurin (CN) whose activity controls the immune receptor-med
Externí odkaz:
https://doaj.org/article/eb6dfbe4c8154dddb41e4bd4dde58bb0
Autor:
Ingo Klein, Florian W. R. Vondran, Martina Sterneck, Oliver Waidmann, Silvio Nadalin, Frank Tacke, Utz Settmacher, U. Lindig, Arndt Vogel, Henning Wege, Hans J. Schlitt
Publikováno v:
Zeitschrift für Gastroenterologie. 60:184-191
Zusammenfassung Hintergrund Für das fortgeschrittene hepatozelluläre Karzinom steht uns seit Kurzem ein deutlich erweitertes Spektrum an systemischen Therapieoptionen zur Verfügung. Insbesondere mit den immunonkologischen Kombinationstherapien kö